These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30698802)

  • 21. Splicing regulators: targets and drugs.
    Yeo GW
    Genome Biol; 2005; 6(12):240. PubMed ID: 16356274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the differential affinity of small molecules for noncanonical DNA structures.
    Stefan L; Bertrand B; Richard P; Le Gendre P; Denat F; Picquet M; Monchaud D
    Chembiochem; 2012 Sep; 13(13):1905-12. PubMed ID: 22930447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes.
    Chwalenia K; Qin F; Singh S; Li H
    Nucleic Acids Res; 2019 Feb; 47(4):e24. PubMed ID: 30590765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splice-switching small molecules: A new therapeutic approach to modulate gene expression.
    Taladriz-Sender A; Campbell E; Burley GA
    Methods; 2019 Sep; 167():134-142. PubMed ID: 31203161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An RNA hairpin to G-quadruplex conformational transition.
    Bugaut A; Murat P; Balasubramanian S
    J Am Chem Soc; 2012 Dec; 134(49):19953-6. PubMed ID: 23190255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of selective ligands for telomeric RNA G-quadruplexes (TERRA) through 19F-NMR based fragment screening.
    Garavís M; López-Méndez B; Somoza A; Oyarzabal J; Dalvit C; Villasante A; Campos-Olivas R; González C
    ACS Chem Biol; 2014 Jul; 9(7):1559-66. PubMed ID: 24837572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of structure on pre-mRNA processing and stability.
    Soemedi R; Cygan KJ; Rhine CL; Glidden DT; Taggart AJ; Lin CL; Fredericks AM; Fairbrother WG
    Methods; 2017 Aug; 125():36-44. PubMed ID: 28595983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X.
    Weldon C; Dacanay JG; Gokhale V; Boddupally PVL; Behm-Ansmant I; Burley GA; Branlant C; Hurley LH; Dominguez C; Eperon IC
    Nucleic Acids Res; 2018 Jan; 46(2):886-896. PubMed ID: 29156002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRAS: High-Throughput Identification of Novel Alternative Splicing Regulators.
    Zheng S
    Methods Enzymol; 2016; 572():269-89. PubMed ID: 27241759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high-throughput assay to identify small-molecule modulators of alternative pre-mRNA splicing.
    Arslan AD; He X; Wang M; Rumschlag-Booms E; Rong L; Beck WT
    J Biomol Screen; 2013 Feb; 18(2):180-90. PubMed ID: 22972848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives.
    Xiong YX; Huang ZS; Tan JH
    Eur J Med Chem; 2015 Jun; 97():538-51. PubMed ID: 25466923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragile X mental retardation protein recognizes a G quadruplex structure within the survival motor neuron domain containing 1 mRNA 5'-UTR.
    McAninch DS; Heinaman AM; Lang CN; Moss KR; Bassell GJ; Rita Mihailescu M; Evans TL
    Mol Biosyst; 2017 Jul; 13(8):1448-1457. PubMed ID: 28612854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Throughput Screening Method to Identify Alternative Splicing Regulators.
    Stork C; Zheng S
    Methods Mol Biol; 2018; 1755():65-74. PubMed ID: 29671263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
    Boon-Unge K; Yu Q; Zou T; Zhou A; Govitrapong P; Zhou J
    Chem Biol; 2007 Dec; 14(12):1386-92. PubMed ID: 18096507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-line probing of RNA G-quadruplexes.
    Beaudoin JD; Jodoin R; Perreault JP
    Methods; 2013 Nov; 64(1):79-87. PubMed ID: 23500045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
    Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-quadruplex formation of FXYD1 pre-mRNA indicates the possibility of regulating expression of its protein product.
    Dhayan H; Baydoun AR; Kukol A
    Arch Biochem Biophys; 2014 Oct; 560():52-8. PubMed ID: 25051342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-quadruplex virtual drug screening: A review.
    Monsen RC; Trent JO
    Biochimie; 2018 Sep; 152():134-148. PubMed ID: 29966734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trans-splicing and alternative-tandem-cis-splicing: two ways by which mammalian cells generate a truncated SV40 T-antigen.
    Eul J; Graessmann M; Graessmann A
    Nucleic Acids Res; 1996 May; 24(9):1653-61. PubMed ID: 8649982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
    Urbanski LM; Leclair N; Anczuków O
    Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.